The store will not work correctly when cookies are disabled.
4-[3-(2-Fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ol
ID: ALA1083083
PubChem CID: 24937759
Max Phase: Preclinical
Molecular Formula: C17H20FN3O3S
Molecular Weight: 365.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CNCC(O)CCN1c2ccccc2N(c2ccccc2F)S1(=O)=O
Standard InChI: InChI=1S/C17H20FN3O3S/c1-19-12-13(22)10-11-20-16-8-4-5-9-17(16)21(25(20,23)24)15-7-3-2-6-14(15)18/h2-9,13,19,22H,10-12H2,1H3
Standard InChI Key: PHSDSMUCNUCJGQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
16.9819 -5.4916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9807 -6.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6956 -6.7319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6938 -5.0789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4091 -5.4880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4094 -6.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1999 -6.5749 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6882 -5.9031 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.1994 -5.2310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5966 -7.2949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1677 -8.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5647 -8.7233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3904 -8.7408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8175 -8.0300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4181 -7.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8433 -6.6036 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.0958 -5.1833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4000 -6.3125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6042 -4.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4291 -4.5037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8340 -3.7849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6590 -3.7762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0639 -3.0593 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8888 -3.0515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4140 -3.0749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
12 13 2 0
3 6 2 0
13 14 1 0
1 2 2 0
14 15 2 0
15 10 1 0
7 10 1 0
5 4 2 0
15 16 1 0
6 7 1 0
8 17 2 0
7 8 1 0
8 18 2 0
8 9 1 0
9 19 1 0
9 5 1 0
19 20 1 0
4 1 1 0
20 21 1 0
5 6 1 0
21 22 1 0
10 11 2 0
22 23 1 0
23 24 1 0
11 12 1 0
21 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 365.43 | Molecular Weight (Monoisotopic): 365.1209 | AlogP: 2.00 | #Rotatable Bonds: 6 |
Polar Surface Area: 72.88 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.92 | CX LogP: 1.11 | CX LogD: -1.33 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.82 | Np Likeness Score: -0.53 |
References
1. O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P.. (2010) Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231)., 53 (11): [PMID:20462211] [10.1021/jm100053t] |